Foresite Capital Management V, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Foresite Capital Management V, Llc disclosed 9 stock positions valued at approximately $362.20M as of quarter-end June 30, 2026. The largest holdings include ALUMIS INC., CG Oncology, Inc., and Disc Medicine, Inc..
- Report Period
- June 30, 2026
- No. of Stocks
- 9
- Portfolio Value
- $362.20M
Holdings by Sector
Foresite Capital Management V, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| ALUMIS INC. | ALMS | Healthcare | 45.81% | 5,896,995 | - | - | $165,941,439 |
| CG Oncology, Inc. | CGON | Healthcare | 21.17% | 1,079,050 | +75,000 | +7.47% | $76,666,503 |
| Disc Medicine, Inc. | IRON | Healthcare | 7.55% | 374,069 | - | - | $27,359,407 |
| Hims & Hers Health, Inc. | HIMS | Consumer Defensive | 7.07% | 738,151 | - | - | $25,591,695 |
| Pharvaris N.V. | PHVS | Healthcare | 6.34% | 664,142 | +470,017 | +242.12% | $22,966,030 |
| Eikon Therapeutics, Inc. | EIKN | Healthcare | 4.75% | 1,318,983 | - | - | $17,212,728 |
| Odyssey Therapeutics, Inc. | ODTX | Healthcare | 3.68% | 713,105 | +713,105 | +100.00% | $13,342,195 |
| Lyell Immunopharma, Inc. | LYEL | Healthcare | 1.85% | 476,386 | -692 | -0.15% | $6,693,223 |
| Nurix Therapeutics, Inc. | NRIX | Healthcare | 1.77% | 265,000 | - | - | $6,428,900 |
Showing 9 of 9 holdings in the latest reporting period.